Home World News EMA Recommends Extension of Therapeutic Indications for Cetuximab World News EMA Recommends Extension of Therapeutic Indications for Cetuximab By Ogkologos - August 14, 2026 162 0 Facebook Twitter Google+ Pinterest WhatsApp New indications concern the treatment of adult patients with BRAF V600E-mutated mCRC in combination with encorafenib Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Activity of Targeted/Immune Therapy Approach in Patients with Advanced Urothelial Cancer May 11, 2021 Promising Results Are Provided by Tebentafusp in Metastatic Uveal Melanoma December 12, 2020 ASCO Annual Meeting 2023: Radiation Therapy May Not Be Needed After... June 6, 2023 Women with Diabetes Less Likely to Opt into Cancer Screening, Despite... October 25, 2019 Load more HOT NEWS Mortality From PSA-Detected Localised Prostate Cancer Remains Very Low Regardless of... Regular Exercise May Help Guard Breast Cancer Patients From Chemo Brain Neoadjuvant PD1/PD-L1 Blockade Combined with Chemotherapy Associated with High Resectability and... Adjuvant Capecitabine-Containing Regimen Improves Modestly Overall Survival in Patients with Early...
